Low-molecular-weight heparins and heparinoids in acute ischemic stroke : a meta-analysis of randomized controlled trials.
about
Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic strokeLow-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic strokePrevention of venous thromboembolism after acute ischemic strokePrevention of deep venous thrombosis and pulmonary embolism following stroke: a systematic review of published articlesRole of heparin and low-molecular-weight heparins in the management of acute ischemic strokeTargeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials.Stroke management.Medical management of stroke.Pharmacological interventions for stroke: failures and future.Risk of thromboembolism following acute intracerebral hemorrhageRETRACTED: Systematic study of cilostazol on secondary stroke prevention: a meta-analysisTreatments for stroke.The economic impact of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism in acute ischemic stroke patientsAntithrombotic trials in acute ischaemic stroke: a selective review.Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patientsSystematic review and stratified meta-analysis of the efficacy of RhoA and Rho kinase inhibitors in animal models of ischaemic stroke.Clinical benefit of early anticoagulation in cardioembolic stroke.Coronary risk stratification in patients with ischemic stroke or transient ischemic stroke attack.Systematic reviews as a tool for planning and interpreting trials.The safety and usefulness of low molecular weight heparins and unfractionated heparins in patients with acute stroke.Singapore ministry of health clinical practice guidelines on stroke and transient ischemic attacks.Consistency and completeness of reported outcomes in randomized trials of primary immunosuppression in kidney transplantation.The intensive care management of acute ischemic stroke: an overview.Venous thromboembolic event prevention in acute stroke: update on evidence and recommendations.Changes in mortality patterns following total hip or knee arthroplasty over the past two decades: a nationwide cohort study.Preventing deep vein thrombosis after stroke: strategies and recommendations.Trafermin for stroke recovery: is it time for another randomized clinical trial?Hemorrhagic cardioembolic stroke secondary to a left ventricular thrombus: a therapeutic dilemma.Deep vein thrombosis after total hip arthroplasty and total knee arthroplasty in patients with previous ischemic stroke.Deep vein thrombosis following ischemic stroke among Asians.Pulmonary embolism after brain hemorrhage in a hypertensive patient: the therapeutic dilemma.Deep Vein Thrombosis in Acute Stroke - A Systemic Review of the Literature.Acute myocardial infarction and heart failure in acute stroke patients: frequency and influence on clinical outcome.
P2860
Q24241831-22B527BC-995B-44BD-9348-4E66D0EDC976Q24244100-932C7154-6B8B-4F96-9920-36D42200BAFCQ28176937-991587FE-0A4F-4469-AD73-832258485A03Q28217686-FF1ECB24-978C-4FCB-B082-A40D64DB123EQ28218271-BBCAEFAB-C012-46F0-86DC-3F29C7A4C45BQ30621033-BCB3B897-53BF-4A84-9990-8E646AD25329Q33928297-9470B561-7A23-4021-B8E1-1B477F0465C6Q34187207-203F832A-9798-4FAD-B7BE-E6DC91BBEDBAQ34628650-4B563952-C816-485C-9876-46C09E01300BQ35018742-B0544B61-1ABF-4C00-966B-D556C3F00DB0Q35061792-89EBC8D5-8DB3-42FB-8D20-E1B5AFBCF8D8Q35581150-210BE033-AF02-4117-B8CA-759A1C128D47Q35939263-136FBB17-9A05-41A9-AFB0-0E756E3A8013Q35967397-9DBAAB30-4BAC-467E-A165-E7E0554C57ADQ36536307-3457017E-FB84-41E9-AE17-F9CE6CA61F7EQ36880679-6DF2241C-3C90-4E6B-B5F8-F301AA6468D3Q37095722-41A87406-9380-4133-BD02-157D1E615D5FQ37244467-3E1485EF-A4E8-4636-855D-293D96AADC7EQ37399439-766471EB-988E-4AFD-9D8C-B38456E7F8DAQ37554499-D33B720F-AE7E-40A3-8341-B3C072240CDCQ37873970-A52A1DF6-BBF6-49E7-B870-23562A7EE376Q38150483-354618F2-DA2A-4AD8-8360-969003E7C470Q38198543-F263367E-9810-44DF-BFD7-1033E308B194Q38365369-41D60415-2E37-4467-95B3-D550BD4FA254Q38422371-55AC9B34-1BDD-487A-B384-5EA398AC64A8Q38923015-D2172D94-3ECA-4E1D-82A5-FE29D1118FF5Q42614796-738A2158-BB5B-426C-80DB-2BC818E035BAQ43143226-995C7BA4-9F7C-44EC-8BF7-F6D3D7E38690Q43484858-950E6FB2-7161-4102-A435-975DAAB6C5F7Q45243381-35C437EA-51EE-4B91-937F-016382026AEFQ48153666-C4AD0B5D-1C76-44BE-9DC5-1F3672C16FC9Q52674793-5A94A326-8826-415D-9364-FC7D8D6AC05FQ53218160-BECB1987-E833-4726-9F35-6A0720E15870
P2860
Low-molecular-weight heparins and heparinoids in acute ischemic stroke : a meta-analysis of randomized controlled trials.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Low-molecular-weight heparins ...... randomized controlled trials.
@ast
Low-molecular-weight heparins ...... randomized controlled trials.
@en
type
label
Low-molecular-weight heparins ...... randomized controlled trials.
@ast
Low-molecular-weight heparins ...... randomized controlled trials.
@en
prefLabel
Low-molecular-weight heparins ...... randomized controlled trials.
@ast
Low-molecular-weight heparins ...... randomized controlled trials.
@en
P2093
P356
P1433
P1476
Low-molecular-weight heparins ...... randomized controlled trials.
@en
P2093
P304
P356
10.1161/01.STR.31.7.1770
P407
P577
2000-07-01T00:00:00Z